interviews

In this edition: 1. Training In Depression And Suicide: Need For Change? Stan Kutcher, Dalhousie University, Nova Scotia 2. Suicide Paradox Explained: Australian National Strategy Barry Nurcombe, Prin

Scientific Editors: George Canellos (Boston), Pat Price (Manchester), Gianni Bonadonna (Milan), Gordon McVie (Milan) Commenting Expert: Emiel Rutgers, Netherlands Cancer Institute, Amsterdam Angel Rod

Paul Fisher REFERENCE: Meet the Professor Session, AACR 2007, Los Angeles PAUL FISHER, Columbia University, New York Patients with cancer could soon be treated with adenoviruses capable of infecting b

Julie Gralow Charles Geyer Judith Bliss Robert Coleman Julie Gralow, from the Fred Hutchinson Cancer Research Center in Seattle, joins Derek Thorne to talk about the latest news from the ASCO annual m

George Canellos Carmela Pepe John Goldman Roy Herbst Sandra Horning George Canellos, from the Dana-Farber Cancer Institute in Boston, joins Derek Thorne to talk about the first day’s news at the

Bevacizumab: New Option for Breast Cancer REFERENCE: 5th European Breast Cancer Conference, Nice, 21st – 25th March 2006 Robin Zon, Michiana Hematology Oncology, South Bend, Indiana Bevacizumab

Myeloablative Radioimmunotherapy Eases Autologous Stem Cell Transplantations in Patients Age 60 years or Older With Relapsed or Refractory B-Cell Lymphoma ABSTRACT: 2005 American Society of Hematology

Tamoxifen After Chemotherapy Protects Premenopausal Patients with Breast Cancer ABSTRACT: J Clin Oncol 24:1322, 2006 Gordon McVie, European Institute of Oncology, Milan The use of tamoxifen after chem

Thalidomide Adds to Multiple Myeloma Chemotherapy Benefit in Older Patients ABSTRACT: Lancet 2006;367:825 George Canellos, Dana-Farber Cancer Institute, Boston The combination of thalidomide together